NettetJointechlabs Inc. (JTL) desires to be the worldwide leader in point-of-care regenerative medicine therapies. Our FDA approved device MiniTC, and CE Mark pend... Nettet11. jan. 2024 · Jointechlabs, Inc. Katz, N., Koukharenko, V. and Geldner, P. Testing the assumption that adding purified autologous adipose-derived mesenchymal stem cells (ADMSC) could improve the survival of fat transplants. Home » Industry Research » Comparison of Different Conditions for the Survival of Human Abdominal Fat in vitro.
Nathan Katz - Co-founder and CEO - Jointhechlabs, Inc …
NettetJointechlabs, Inc. Catarina Hadamitzky, Tatiana S. Zaitseva, Nathan Katz, Claire P Edelstein, Manuel T. Escarraman, Dung Nguyen, Michael V. Paukshto To address the limitations of current treatments for secondary lymphedema, a group developed an experimental surgical procedure based on Autologous Lymph Node Fragment (ALNF) … NettetJointechlabs Inc. is an emerging leader in point-of-care regenerative and rejuvenation medicine therapies. MiniTC® helps injured tissue heal in... lithium ion ba
Jointechlabs Inc. is an emerging... - Jointechlabs Inc. - Facebook
NettetJointechlabs is a regenerative medicine solutions company based in California providing FDA-cleared technology that empowers safe, cost-effective point-of-care regenerative medicine therapies to eliminate pain and suffering, and make you look and feel better. NettetJointechlabs, Inc. Thomas Lawson Director, Regulatory Affairs 8 Graystone Court North Barrington, Illinois 60010 Re: K182732 Trade/Device Name: Jtl-250-01 Regulation … Nettet1. apr. 2024 · Stemtech LLC has made 2 investments. Their most recent investment was on Apr 1, 2024, when Jointechlabs, Inc. raised $25K. How many investments has this organization made over time? Which industries has this organization most actively invested in? Unlock even more features with Crunchbase Pro Start Your Free Trial impurity\\u0027s 1